EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression

Maolin Tang, Shisheng Zhao, Ling Ren, Qianqian Li, Li Li, Chaoli Wang, Chunmei Meng, Yuling Chen, Weimin Hu

Frontiers in Bioscience-Landmark · 2024

DOI: 10.31083/j.fbl2904138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Maolin Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, North Sichuan Medical College, 637100 Nanchong, Sichuan, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Biomarkers, Tumor, Disease Progression. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cooperation Project on Scientific Research between Nanchong City and North Sichuan Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mounting evidence indicates that complement components play a crucial role in cancer progression. Recent findings indicate that certain complement components display a significant rise in expression within esophageal squamous cell carcinoma (ESCC). However, the specific tumorigenic functions of these components remain unclear. This study focuses on investigating the expression pattern of C1r, elucidating a role for C1r in ESCC, as well as exploring underlying mechanisms controlled by C1r.

Methods

The expression of C1r in ESCC tissues, malignant epithelial cells, and its relationship with survival were analyzed using the Gene Expression Omnibus (GEO) database and tissue microarrays. Single-cell RNA sequencing (scRNA-seq) was used to study the expression of C1r in malignant epithelial cells. C1r knockdown or C1r overexpression in cultured ESCC cells were used to assess the effects of C1r on proliferation, migration, invasion, cell-matrix adhesion, apoptosis, and growth of xenografted tumors in immunocompromised (nude) mice. Western blotting was used to detect the expression of MMP-1 and MMP-10 in C1r knockdown or C1r overexpressing ESCC cells.

Results

C1r was highly expressed in ESCC tissues, malignant epithelial cells, and cultured ESCC cell lines. High C1r expression indicated a poor prognosis. Knockdown of C1r significantly suppressed the proliferation, migration, invasion, cell-matrix adhesion, and promoted apoptosis in cultured ESCC cells. Additionally, knockdown of C1r markedly inhibited tumor growth in nude mice. Overexpression of C1r had the opposite effects. C1r induced the expression of MMP-1 and MMP-10.

Conclusions

C1r is highly expressed in ESCC and promotes the progression of this tumor type. Our findings suggest that C1r may serve as a novel prognostic biomarker and therapeutic target in ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaBiomarkers, TumorDisease ProgressionMice, NudeComplement C1rCell ProliferationHumansAnimalsPrognosisCell Line, TumorCell MovementApoptosisMiceMaleFemaleGene Expression Regulation, NeoplasticMatrix Metalloproteinase 1Carcinoma, Squamous Cell

Stichwörter der Autor:innen

biomarkercomplement component C1resophageal squamous cell carcinoma (ESCC)malignant progressionsingle-cell RNA sequencing (scRNA-seq)

Substanzen

Biomarkers, TumorComplement C1rMatrix Metalloproteinase 1

Autor:innen und Institutionen

  • Department of Immunology, North Sichuan Medical College, 637100 Nanchong, Sichuan, China.
  • Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, 637100 Nanchong, Sichuan, China.
  • Department of Pathology, North Sichuan Medical College, 637100 Nanchong, Sichuan, China.

Förderung

  • Cooperation Project on Scientific Research between Nanchong City and North Sichuan Medical College

Zitieren

APA

Tang, M., Zhao, S., Ren, L., Li, Q., Li, L., Wang, C., Meng, C., Chen, Y., & Hu, W. (2024). Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2904138

Vancouver

Tang M, Zhao S, Ren L, Li Q, Li L, Wang C, et al. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2904138

BibTeX
@article{Tang2024,
  author = {Tang, Maolin and Zhao, Shisheng and Ren, Ling and Li, Qianqian and Li, Li and Wang, Chaoli and Meng, Chunmei and Chen, Yuling and Hu, Weimin},
  title = {Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  doi = {10.31083/j.fbl2904138}
}
Kostenlos starten →